Posted by on Jan 28, 2021 in Breast cancer | 0 comments

In a nutshell

This trial is looking to examine the use of radiation on a shorter schedule of 5 days in a row is a safe and effective way to prevent breast cancer (BC) from coming back in people who have had a mastectomy (surgical removal of the breast). The main outcomes that are to be measured are local and regional disease recurrence. This trial is to be carried out in New York, the United States. 

The details

BC is one of the most common cancers found in women globally. The standard treatment for BC is surgery, chemotherapy, and radiotherapy.

This trial examines the effectiveness of a compressed or shorter radiotherapy treatment schedule on BC recurrence following breast reconstruction surgery. The main outcomes to be measured are local and regional cancer recurrence.

Who are they looking for?

This trial is looking to recruit 72 patients who have had chest wall reconstruction following breast removal surgery. 

Patients will be excluded from this trial if they have cancer spread to distant body parts (metastases) or have had radiation therapy to the torso. Patients with uncontrolled infections of medical conditions, another cancer, or who are receiving anti-cancer treatment will also be excluded. Women who are breastfeeding or are pregnant will not be allowed to participate.

How will it work

All patients in the trial will receive external beam radiotherapy. This will be given in 5 treatments on 5 consecutive days during 1 week. Each dose will be 5.2 Gy.

Participants will be followed up for 3 years and disease recurrence and complications will be evaluated.

Clinical trial locations

Locations near 20147, United States (Change):
Please enter zip/postal code and country to help us offer locations near you
Show only recruiting locations
Study ID:NCT04648904
Want personalized notifications? Get notified only when trials are matching for you.
(it's free)